Salute e Benessere

Cystic Fibrosis Therapeutics Market to Grow Substantially by 2029 - Brandessence…

Key Takeaways Key Takeaways The Global Cystic Fibrosis Therapeutics Market is valued atUSD 10.74 Billionin 2022 and is expected to reachUSD 30.71 Billionby 2029 with a CAGR of 16.2% over the forecast period. Get Sample of Report@https://brandessenceresearch.com/downloadSample/PostId/2590 Key Trends and Dynamics of Global Cystic Fibrosis Market Increasing prevalence and diagnosis of cystic fibrosis, along with rising popularity of personalized medicine and...
PR Newswire
18/05/2023

Telesis Bio Announces First Commercial Shipment of BioXp® NGS Library Prep Kit

New Kit Enables Automation of NGS Library Prep on the BioXp® System Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Molecular Biology Workstation BioXp ®NGS Library Prep kit for Plasmid Sequencing. This NGS Library Prep kit enables on-demand and automated library preparation of plasmid DNA for use in next-generation sequencing applications. Leveraging this new automation capability of the BioXp ®platform is expected to enable researchers in high-throughput...
Nasdaq GlobeNewswire
18/05/2023

The First of Its Kind in the World: The Recombinant Multivalent COVID-19 Protein…

Coviccine® Bivalent-- Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) Coviccine® Bivalent-- Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) The Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) is an upgraded version of Coviccine® --Recombinant COVID-19 Vaccine (Sf9 cell) developed by WestVac Biopharma. Studies have shown that the vaccine induced high titers of neutralizing antibodies against multiple…
PR Newswire
18/05/2023

HitGen Announces Drug Discovery Research Agreement with ARase Therapeutics

"We are very excited to work with HitGen. They will be instrumental in progressing our preclinical portfolio and we look forward to leveraging their screening platform and drug discovery capabilities in combination with our deep expertise in ADP-ribosylation and drug development," said Paul Chang PhD. CEO/CSO and founder, ARase Therapeutic. "We are very excited to work with HitGen. They will be instrumental in progressing our preclinical portfolio and we look forward to leveraging…
PR Newswire
18/05/2023

inHEART RECEIVES CE CERTIFICATION UNDER NEW MDR FOR NOVEL, AI-BASED, DIGITAL…

Additional features of the inHEART solution already available in the US and now available in Europe with the new CE Mark MDR certification include new information (scar transmurality and left atrium wall thickness), new visualization and measurement tools, and an enhanced user experience. Additional features of the inHEART solution already available in the US and now available inEuropewith the new CE Mark MDR certification include new information (scar transmurality and left atrium wall...
PR Newswire
18/05/2023

GEEKVAPE Wins "Industry Leader" At The 2023 Vapouround Global Awards

GEEKVAPE won the "Industry Leader" award this year, which is a testament to its strength, representing both the high-end design of the product and the authoritative recognition of the R&D strength behind it, in addition to the high recognition of GEEKVAPE's position as the industry leader in vaping devices. GEEKVAPE won the "Industry Leader" award this year, which is a testament to its strength, representing both the high-end design of the product and the authoritative…
PR Newswire
18/05/2023

Ajinomoto Bio-Pharma Services Announces Leadership Changes at US Facility

Mr. Blagg joins Aji Bio-Pharma with 34 years of experience providing cross functional operations leadership in regulated industries including 23 years in the bio-pharmaceutical field. He has served in a variety of senior leadership roles at Revance Therapeutics, PDL Biopharma, and XOMA Corporation in addition to serving as a well-respected industry consultant. As Executive Vice President, Operations, Mr. Blagg is responsible for the Drug Product, Drug Substance, Label/Packaging, and…
PR Newswire
18/05/2023

DISCOVERY LIFE SCIENCES JOINS AKOYA BIOSCIENCES' GLOBAL SERVICE PROVIDER NETWORK…

As a qualified provider, Discovery has received additional tools for quantitative QC of future panels and operator and autostainer consistency. The company's pathologist-driven, CAP-accredited, CLIA-certified, and GCLP-compliant multiplex immunofluorescence (mIF) assay development program draws heavily on decades of expertise in histopathology as well as experience in virtual microscopy powered by artificial intelligence and machine learning. Akoya's spatial imaging technologies enhance…
PR Newswire
18/05/2023

New Veeva Link MedTech Provides Real-Time Data to Optimize Scientific Engagement

Link MedTech equips medical affairs and commercial teams with real-time data to effectively engage with customers and key opinion leaders (KOLs). With access to validated data on key experts, teams can drive precise and relevant engagement from the start. Link MedTech equips medical affairs and commercial teams with real-time data to effectively engage with customers and key opinion leaders (KOLs). With access to validated data on key experts, teams can drive precise and relevant engagement...
PR Newswire
18/05/2023

Global Medium Chain Triglycerides Market Expected to Grow Substantially Owing to…

As per the report published by Research Dive, the global medium chain triglycerides market is expected to register a revenue of $2,959.9 million by 2031 at a CAGR of 6.6% during the forecast period 2022-2031. As per the report published by Research Dive, theglobal medium chain triglycerides market is expected to register a revenue of$2,959.9 millionby 2031 at a CAGR of 6.6% during the forecast period 2022-2031. Segments of the Medium Chain Triglycerides Market The report...
PR Newswire
18/05/2023

Exosomes Market Set for Substantial Growth, Forecasted to Exceed US$ 1,955.3…

Exosomes are secreted by all cell types and found in urine, saliva, plasma, breast milk, semen, amniotic fluid, cerebral spinal fluid (CSF), synovial fluid, bronchial fluid, lymph, bile and others. Exosomes play multiple roles in cancer disease, such as in angiogenesis, drug resistance, and metastatic spread. Exosomes are secreted by all cell types and found in urine, saliva, plasma, breast milk, semen, amniotic fluid, cerebral spinal fluid (CSF), synovial fluid, bronchial fluid, lymph,...
PR Newswire
18/05/2023

Patio Doors Market to Reach $59.3 Billion, Globally, by 2032 at 4.6% CAGR…

Download Free Sample Report @ https://www.alliedmarketresearch.com/request-sample/33842 Download Free Sample Report @https://www.alliedmarketresearch.com/request-sample/33842 Prime determinants of growth The global patio doors market is driven by factors such as a rising popularity of outdoor living spaces, rapid urbanization & industrialization, surge in residential & non-residential construction, increase in consumer spending on home remodeling, growing desire by...
PR Newswire
18/05/2023

Non-Alcoholic Steatohepatitis Biomarkers Market Booming: Projected Market Value…

Non-alcoholic steatohepatitis (NASH) is the type of liver disease where fats build up in liver of alcoholic or non-alcoholic people and causes inflammation and damage to cells in liver leading to cirrhosis and failure of liver. Non-alcoholic steatohepatitis biomarker are used as diagnostic tool to measure severity of non-alcoholic steatohepatitis for liver damage assessment. Growing prevalence of liver diseases and demand for non-invasive diagnostic tools for detection of NASH has...
PR Newswire
18/05/2023

European study highlights need to improve the quality of conversations about…

IoL is one of the most frequently performed obstetric interventions globally [2] . The survey findings suggest that obstetricians and midwives make a difference by actively enhancing the dialogue with expectant mothers to support the collaborative decision-making process. [1] The study demonstrates a clear need to increase the provision of more detailed and timely information about IoL to expectant mothers, to further support their informed choices about IoL. [1] IoL is one of the most...
PR Newswire
18/05/2023

Women's Health Market to Reach $63.02 Billion by 2030: Grand View Research, Inc.

Read 130 page market research report, "Women's Health Market Size, Share & Trends Analysis Report By Application (Postmenopausal Osteoporosis, Hormonal Infertility, Endometriosis & Uterine Fibroids, Contraceptives), By Age, By Region, And Segment Forecasts, 2023 - 2030", published by Grand View Research. Read 130 page market research report, " Women's Health Market Size, Share & Trends Analysis Report By Application (Postmenopausal Osteoporosis, Hormonal Infertility…
PR Newswire
18/05/2023

Top-quality medical grade TPUs enabled by smart factory: ICP DAS - BMP to…

Materials with high consistency are essential for medical device manufacturing. Therefore, ICP DAS - BMP places great importance on quality assurance and performs rigorous testing and thorough quality inspections for each batch of TPU produced. Besides, we constantly upgrade production lines through IIoT solutions to optimize manufacturing processes and increase productivity. The resultant shorter lead times further boost ICP DAS - BMP competitive edge. Materials with high consistency are...
PR Newswire
18/05/2023

ImaginAb Advances Two Solid Tumor Radiopharmaceutical Therapy (RPT) Candidates…

Delta-like ligand 3 (DLL3) is highly selective for SCLC and neuroendocrine tumors, with minimal to no expression in healthy tissues. Given the rapid recurrence of SCLC following existing therapeutic option, there remains a significant need to improve prognosis for patients suffering from this disease. Delta-like ligand 3 (DLL3) is highly selective for SCLC and neuroendocrine tumors, with minimal to no expression in healthy tissues. Given the rapid recurrence of SCLC following existing...
PR Newswire
18/05/2023

Kapruvia® (difelikefalin) recommended by England's NICE for the treatment of…

"The recommendation of Kapruvia® by NICE is a key step on our journey to bring this breakthrough treatment to in-centre haemodialysis patients living with moderate-to-severe CKD-associated pruritus in the UK," said Fabio Dorigotti, Head Global Medical Affairs of CSL Vifor. "We look forward to continue working with the National Health Service to ensure access to this important medicine for patients as quickly as possible." "The recommendation of Kapruvia ® by NICE is a…
PR Newswire
18/05/2023

Addex Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland,May18 , 2022-Addex Therapeutics(SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development (theCompany ), announced today that it had received written notification from Nasdaq indicating that, for the last thirty consecutive business days, the bid price for the Company's American Depositary Shares (ADSs) had closed below...
Nasdaq GlobeNewswire
18/05/2023

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and…

COPENHAGEN, Denmark, May 17, 2023– Bavarian Nordic A/S (OMX: BAVA) announces that the share buy-back program, which was announced and initiated on May 9, 2023, has now been terminated, as the intended number of shares under the program has been repurchased. The program was executed in accordance with the provisions of Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse and supplementing Regulation (EU) 2016/1052 of 8 March 2016, which...
Nasdaq GlobeNewswire
17/05/2023

Cellectis Presents Clinical Data on AMELI-01 and Preclinical Data on Multiplex…

thAmerican Society of Hematology (ASH) annual meeting, as well as preclinical data on multiplex engineering for superior generation of CAR T-cells, at the American Society of Gene and Cell Therapy (ASGCT) 2023 Annual Meeting.Oral presentation:AMELI-01, a study evaluating UCART123, an allogeneic CAR T-cell product candidate, in relapsed/refractory acute myeloid leukemia (r/r AML) The oral presentation highlights the following clinical data: Preliminary Clinical Data from the...
Nasdaq GlobeNewswire
17/05/2023

NANOBIOTIX Provides First Quarter 2023 Operational and Financial Update

Reported €30.2 million in cash and cash equivalents as of March 31, 2023 PARIS and CAMBRIDGE, Mass., May17, 2023(GLOBE NEWSWIRE) --NANOBIOTIX(Euronext: NANO –– NASDAQ: NBTX – the '' Company ''), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today provided an update on operational progress and reported financial results for the for the first quarter of 2023. “2023 will be a foundational year...
Nasdaq GlobeNewswire
17/05/2023

Sanofi: Information concerning the total number of voting rights and shares –…

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of theCode de commerce(the French Commercial Code) and article 223-16 of theRèglementgénéral de l'Autorité des Marchés Financiers(Regulation of the French stock market authority) Sanofi a Frenchsociété anonymewith a registered share capital of 2,521,494,572 € Registered office : 46, avenue de la Grande Armée - 75017 Paris - France...
Nasdaq GlobeNewswire
17/05/2023

AB Science summarizes key messages from its participation to a panel discussion…

PRESS RELEASEAB SCIENCE SUMMARIZES KEY MESSAGES FROM ITS PARTICIPATIONTOA PANEL DISCUSSIONAT THE 2023 ALS DRUG DEVELOPMENT SUMMIT(BOSTON, USA)Paris, 17May , 2023 , 8:00pmCETAB Science SA(Euronext – FR0010557264 – AB) today summarizes the key messages delivered to an audience of key opinion leaders and decision-makers in the field of ALS research and healthcare policy, during an Panel Discussion at the ALS Drug Development Summit in...
Nasdaq GlobeNewswire
17/05/2023
Altri  Comunicati